Back to results
US 2015/0307543 A1Published application
Polymorph
AssigneeOncology Research International Limited
InventorsDavid Millar Walker, Philip Andrew Marshall
Life of this patent
Estimating the term…
Abstract
The present invention relates to a new polymorphic form of the compound diosgenyl α-L-rhamnopyranosyl-(1->2)-β-D-glucopyranoside (compound I) and pharmaceutical compositions containing this polymorph
Claims11
A crystalline form of a compound of the formula:
- which shows on X-ray diffraction a peak on the 2theta scale at 2.96±0.02°.
Dependencies are inferred from the claim text.